Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Park B et al. - Between 1998 and 2005, the number of hospitalized patients with a primary or secondary discharge diagnosis of PE increased from 126,546 to 229,637; hospital case-fatality rates for these patients decreased from 12.3% to 8.2%; length of hospital stay decreased from 9.4 days to 8.6 days; and total hospital charges increased from $25,293 to $43,740. Between 1998 and 2005, significant improvements were observed in outcomes for patients hospitalized with clinically recognized PE, including decreases in mortality and length of hospital stay. Charges for this hospital care increased during this time period.
Related Articles
A Computerized Handheld Decision-Support System to Improve Pulmonary Embolism Diagnosis
Annals of Internal Medicine, 11/17/09
Relevance Score: 69%
Chronobiological Rythms In Onset Of Massive Pulmonary Embolism In Iranian Population
Middle East Journal of Anesthesiology, 10/14/09
Relevance Score: 69%
Prospective Evaluation of Right Ventricular Function and Functional Status Six Months After Acute Submassive Pulmonary Embolism
Chest, 10/14/09
Relevance Score: 68%
A prospective study of the management of non-massive pulmonary embolism in the home
European Journal of Internal Medicine, 10/01/09
Relevance Score: 68%
D-dimer Testing in Patients with Suspected Pulmonary Embolism and Impaired Renal Function
American Journal of Medicine, 11/02/09
Relevance Score: 67%
Today in CV/Thromboembolic...keeping you current
Receive free subspecialty "5-minute updates" via email
High frequency oscillatory ventilation in children: an overview
Respiratory Medicine CME, 12/04/09
Intrapleural hemorrhage after administration of tPA: a case report and review of the literature
Therapeutic Advances in Respiratory Disease, 12/04/09
Telangiectases in scleroderma: A potential clinical marker of pulmonary arterial hypertension
Journal of Rheumatology, 12/03/09
Sponsor
Article Search
Sponsor


See Latest Articles


